Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank43
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-15.97M
↓ 10% vs avg
Percentile
P43
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-14.49M
Historical baseline
PeriodValueYoY Change
TTM$-15.97M-51.3%
2024$-10.55M+36.7%
2023$-16.68M+31.6%
2022$-24.36M-24.7%
2021$-19.54M-73.8%
2020$-11.24M-14.0%
2019$-9.87M-27.7%
2018$-7.73M-